# Essential Amino Acid Supplementation in Older Adult COVID-19 Patients

> **NCT04816071** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **University of Arkansas**

## Conditions studied

- Covid19

## Interventions

- **DRUG:** Essential amino acids
- **DIETARY_SUPPLEMENT:** Maltodextrin

## Key facts

- **NCT ID:** NCT04816071
- **Lead sponsor:** University of Arkansas
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-05-01
- **Primary completion:** 2021-05-01
- **Final completion:** 2021-05-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PI no longer wanted to do the study
- **Last updated:** 2024-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04816071

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04816071, "Essential Amino Acid Supplementation in Older Adult COVID-19 Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04816071. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*